The Journal of Pediatrics
Volume 152, Issue 4 , Pages 571-575 , April 2008

Bisphosphonate Treatment in Chronic Recurrent Multifocal Osteomyelitis

Received 2 March 2007 ,Revised 30 July 2007 ,Accepted 31 August 2007.

References 

  1. Giedion A, Holthusen W, Masel L, Vischer D. Subacute and symmetrical osteomyelitis. Ann Radiol. 1972;15:329–342
  2. Schultz C, Holterhus P, Seidel A, Jonas S, Barthel M, Kruse K, et al. Chronic recurrent multifocal osteomyelitis in children. Ped Infect Dis J. 1999;18:1008–1013
  3. Girschick H, Huppertz H, Harmsen D, Krauspe R, Muller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbal testing. Hum Pathol. 1999;30:59–65
  4. Huber A, Lam P, Duffy C, Yeung R, Ditchfield M, Laxer D, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141:198–203
  5. Girschick H, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64:279–285
  6. Holden W, David J. Chronic recurrent multifocal osteomyelitis: two cases of sacral disease responsive to corticosteroids. Clin Infect Dis. 2005;40:616–619
  7. Carpenter E, Jackson M, Friesen C, Scarbrough M, Roberts C. Crohn’s associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541–544
  8. Deutschmann A, Mache C, Bodo K, Zebedin D, Ring E. Successful treatment of chronic recurrent multifocal osteomyelitis with tumour necrosis factor alpha blockage. Pediatrics. 2005;116:1231–1233
  9. Gallagher K, Roberts R, MacFarlane J, Stiehm E. Treatment of chronic recurrent multifocal osteomyelitis with interferon gamma. J Pediatr. 1997;131:470–472
  10. Siebel M, Farahmand I, Ziegler R. Succesful treatment of chronic recurrent multifocal osteomyelitis with intravenous bisphosphonates. Exp Clin Endocrinol Diabetes. 1999;107(Supp):S43
  11. Montonen M, Kalso E, Pylkkaren L, Lindstrorm B-M, Lindqvist C. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg. 2001;30:313–317
  12. Compeyrot-Lacassagne S, Rosenberg A, Babyn P, Laxer R. Pamidronate treatment of chronic non-infectious inflammatory lesions of the mandible in children. J Rheumatol. 2007;34:1585–1589
  13. Yamazaki Y, Satoh C, Ishikawa M, Notani K, Nimura K, Kitagawa Y. Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:67–71
  14. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339:947–952
  15. Zacharin MR, Kanumakala S. Pamidronate treatment of less severe forms of osteogenesis imperfecta in children. J Paediatr Endocrinol Metab. 2004;17:1511–1517
  16. Kerrison C, Davidson J, Cleary A, Beresford M. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology. 2004;43:1246–1251
  17. Van den Wyngaert T, Huizing M, Vermorken J. Osteonecrosis of the jaw related to the use of bisphosphonates. Curr Opin Oncol. 2007;19:315–322
  18. Chan B, Zacharin M. Maternal and infant outcome after pamidronate treatment of fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab. 2006;91:2017–2020
  19. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60:68–73
  20. Liens D, Delmas PD, Meunier PJ. Long term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343:953–954
  21. Toussirot E, Wending D. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Curr Opin Rheumatol. 2007;19:340–345
  22. Dicunzo G, Vincenzi B, Santini D, Avvisati G, Rocci L, Battistoni F, et al. Fever after zolendronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res. 2003;23:649–654
  23. Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK. The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphoantes is inhibited by statins. Clin Exp Immunol. 2005;139:101–111

PII: S0022-3476(07)00848-7

doi: 10.1016/j.jpeds.2007.08.047

The Journal of Pediatrics
Volume 152, Issue 4 , Pages 571-575 , April 2008

Article Tools

* Image Usage & Resolution